Penicillamine

Penicillamine

SCHEMBL7531420

CC(=O)C=O.CC(C)(S)[C@@H](N)C(=O)O

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.75
MAPT P10636 1/20 0.75
PTGS1 P23219 1/20 0.75
GRIK1 P39086 1/20 0.32
SLC1A3 P43003 1/20 0.30
SLC1A2 P43004 1/20 0.30
SLC1A1 P43005 1/20 0.30
SLC7A5 Q01650 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dl-Penicillamine SCHEMBL952027 0.87 ALDH1A1 (0.90) ALDH1A1MAPTPTGS1GRIK1SLC1A3
Penicillamine SCHEMBL952026 0.87 ALDH1A1 (0.90) ALDH1A1MAPTPTGS1GRIK1SLC1A3
Dl-Penicillamine SCHEMBL159653 0.87 ALDH1A1 (1.00) ALDH1A1MAPTPTGS1GRIK1SLC1A3
Dl-Penicillamine SCHEMBL22322162 0.87 ALDH1A1 (1.00) ALDH1A1MAPTPTGS1GRIK1SLC1A3
Penicillamine SCHEMBL4343 0.87
Penicillamine SCHEMBL129296 0.87 ALDH1A1 (1.00) ALDH1A1MAPTPTGS1GRIK1SLC1A3
Dl-Penicillamine SCHEMBL57527 0.87
Dl-Penicillamine SCHEMBL4344 0.87
Penicillamine SCHEMBL603349 0.87 ALDH1A1 (1.00) ALDH1A1MAPTPTGS1GRIK1SLC1A3
Dl-Penicillamine SCHEMBL7932150 0.84 ALDH1A1 (0.95) ALDH1A1MAPTPTGS1GRIK1SLC1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020156134-A1 Method and use of alpha-amino-beta-mercapto-ethane derivatives as dicarbonyl scavengers for treatment of conditions resulting from protein, lipid, and DNA damage JACOBSON ELAINE L (US) 2002-10-24 US disclosed
US-6417235-B2 INHIBITING PRODUCTION OF ADVANCED GLYCOSYLATION END PRODUCTS IN A PATIENT COMPRISING ADMINISTERING TO THE PATIENT D-PENICILLAMINE, L-PENICILLAMINE, AND D,L-PENICILLAMINE UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 2002-07-09 US disclosed
US-20010051658-A1 Method and use of penicillamines and other alpha-amino-beta,beta-mercapto-beta,beta-dimethyl-ethane derivatives as dicarbonyl scavengers for treatment of conditions resulting from protein, lipid, and DNA damage NIADYNE, INC. 2001-12-13 US disclosed